与长期阿达利穆马布治疗相关的长度扩展横侧髓炎:一个诊断挑战
José M Valdés1, Belén Roa2, Patricia Orellana3
1Neurology and Psychiatry Department, Clinica Alemana, Av Vitacura 5951, Vitacura, 10th Floor, Santiago Region Metropolitana, Santiago CL 763000, Chile.
Clinical neurology and neurosurgery
|June 29, 2025
概括
一名患有类风湿性关节炎 (RA) 的患者在接受了阿达利姆巴治疗后出现骨髓病变. 这突显了TNF-α抑制剂的神经副作用的风险,如纵向扩展横向肌痛炎 (LETM).
科学领域:
- 神经免疫学 神经免疫学
- 类风湿病学 类风湿病学
背景情况:
- 类风湿性关节炎 (RA) 是一种自身免疫性疾病,通常用TNF-α抑制剂治疗.
- 阿达利穆马布是一种常见的RA生物疗法.
更多相关视频
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
2.6K
05:55Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
972
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
